Sangon Biotech: difference between revisions
Diff·revision 16 → 17·23:26, 13 Feb 2025
Difference between revision 16 and revision 17 of Sangon Biotech. 3 lines changed; the page grew by 301 bytes.
| Revision 16 — 13:22, 8 Feb 2025 EndotoxinEd (talk) promote subsection to section 4,976 bytes +159 | Revision 17 — 23:26, 13 Feb 2025 SemaglutideSasha (talk) correct percentage: source reports placebo-adjusted 5,277 bytes +301 | ||
|---|---|---|---|
| 30 | Purchaser reports describe conventional practice for the peptide lines, with a batch certificate reporting purity and appearance, and water on some lots.{{r|reports}} Reagent-line reports describe documentation typical of the laboratory-supply trade — specification sheets and lot-specific certificates — which is a different documentary tradition from the research-compound sector and generally a more standardised one. | 30 | Purchaser reports describe conventional practice for the peptide lines, with a batch certificate reporting purity and appearance, and water on some lots.{{r|reports}} Reagent-line reports describe documentation typical of the laboratory-supply trade — specification sheets and lot-specific certificates — which is a different documentary tradition from the research-compound sector and generally a more standardised one. |
| 31 | 31 | ||
| + | 32 | No certification claim has been independently corroborated here.{{r|selfpub,gmp}} | |
| + | 33 | ||
| 32 | == References == | 34 | == References == |
| 33 | {{reflist}} | 35 | {{reflist}} |
| ⋮ | ⋮ | ||
| 37 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 39 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 38 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 40 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 41 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | |
| 39 | 42 | ||
| 40 | {{DEFAULTSORT:Sangon Biotech}} | 43 | {{DEFAULTSORT:Sangon Biotech}} |